Authors:
van Dam, M
Stalenhoef, AFH
Wittekoek, J
Trip, MD
Prins, MH
Kastelein, JJP
Citation: M. Van Dam et al., Efficacy of concentrated n-3 fatty acids in hypertriglyceridaemia - A comparison with gemfibrozil, CLIN DRUG I, 21(3), 2001, pp. 175-181
Citation: Afh. Stalenhoef et al., Effect of plant sterol-enriched margarine on plasma lipids and sterols in subjects heterozygous for phytosterolaemia, J INTERN M, 249(2), 2001, pp. 163-166
Authors:
Bredie, SJH
Bosch, FH
Demacker, PNM
Stalenhoef, AFH
van Leusen, R
Citation: Sjh. Bredie et al., Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism, PERIT DIA I, 21(3), 2001, pp. 275-281
Authors:
van Tits, LJH
de Waart, F
Hak-Lemmers, HLM
van Heijst, P
de Graaf, J
Demacker, PNM
Stalenhoef, AFH
Citation: Ljh. Van Tits et al., Effects of alpha-tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers, FREE RAD B, 30(10), 2001, pp. 1122-1129
Authors:
Illingworth, RD
Crouse, JR
Hunninghake, DB
Davidson, MH
Escobar, ID
Stalenhoef, AFH
Paragh, G
Ma, PTS
Liu, M
Melino, MR
O'Grady, L
Mercuri, M
Mitchel, YB
Citation: Rd. Illingworth et al., A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial, CURR MED R, 17(1), 2001, pp. 43-50
Authors:
De Waart, FG
Sehouten, EG
Stalenhoef, AFH
Kok, FJ
Citation: Fg. De Waart et al., Serum carotenoids, alpha-tocopherol and mortality risk in a prospective study among Dutch elderly, INT J EPID, 30(1), 2001, pp. 136-143
Authors:
Smilde, TJ
van Wissen, S
Wollersheim, H
Kastelein, JJP
Stalenhoef, AFH
Citation: Tj. Smilde et al., Genetic and metabolic factors predicting risk of cardiovascular disease infamilial hypercholesterolemia, NETH J MED, 59(4), 2001, pp. 184-195
Authors:
Smilde, TJ
van Wissen, S
Wollersheim, H
Trip, MD
Kastelein, JJP
Stalenhoef, AFH
Citation: Tj. Smilde et al., Effect of aggressive versus conventional lipid lowering on atherosclerosisprogression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial, LANCET, 357(9256), 2001, pp. 577-581
Authors:
de Waart, FG
Kok, FJ
Smilde, TJ
Hijmans, A
Wollersheim, H
Stalenhoef, AFH
Citation: Fg. De Waart et al., Effect of glutathione S-transferase M1 genotype on progression of atherosclerosis in lifelong male smokers, ATHEROSCLER, 158(1), 2001, pp. 227-231
Authors:
Lu, KM
Lee, MH
Hazard, S
Brooks-Wilson, A
Hidaka, H
Kojima, H
Ose, L
Stalenhoef, AFH
Mietinnen, T
Bjorkhem, I
Bruckert, E
Pandya, A
Brewer, HB
Salen, G
Dean, M
Srivastava, A
Patel, SB
Citation: Km. Lu et al., Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively, AM J HU GEN, 69(2), 2001, pp. 278-290
Authors:
de Roos, B
Caslake, MJ
Stalenhoef, AFH
Bedford, D
Demacker, PNM
Katan, MB
Packard, CJ
Citation: B. De Roos et al., The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjects, AM J CLIN N, 73(1), 2001, pp. 45-52
Authors:
Smilde, TJ
Trip, MD
Wollersheim, H
van Wissen, S
Kastelein, JJP
Stalenhoef, AFH
Citation: Tj. Smilde et al., Rationale, design and baseline characteristics of a clinical trial comparing the effects of robust vs conventional cholesterol lowering and intima media thickness in patients with familial hypercholesterolaemia - The Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) study, CLIN DRUG I, 20(2), 2000, pp. 67-79
Authors:
de Waart, FG
Smilde, T
Wollersheim, H
Stalenhoef, AFH
Kok, FJ
Citation: Fg. De Waart et al., Smoking characteristics, antioxidant vitamins, and carotid artery wall thickness among life-long smokers, J CLIN EPID, 53(7), 2000, pp. 707-714
Authors:
Netea, MG
Dinarello, CA
Kullberg, BJ
Jansen, T
Jacobs, L
Stalenhoef, AFH
Van der Meer, JWM
Citation: Mg. Netea et al., Oxidation of low-density lipoproteins by acellular components of Chlamydiapneumoniae, J INFEC DIS, 181(5), 2000, pp. 1868-1869
Authors:
Demacker, PNM
Veerkamp, MJ
Bredie, SJH
Marcovina, SM
de Graaf, J
Stalenhoef, AFH
Citation: Pnm. Demacker et al., Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia, ATHEROSCLER, 153(2), 2000, pp. 483-490
Authors:
Stalenhoef, AFH
de Graaf, J
Wittekoek, ME
Bredie, SJH
Demacker, PNM
Kastelein, JJP
Citation: Afh. Stalenhoef et al., The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertrygliceridemia, ATHEROSCLER, 153(1), 2000, pp. 129-138
Authors:
Kroon, AA
van't Hof, MA
Demacker, PNM
Stalenhoef, AFH
Citation: Aa. Kroon et al., The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels, ATHEROSCLER, 152(2), 2000, pp. 519-526
Citation: Mjv. Hoffer et al., The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia, ATHEROSCLER, 151(2), 2000, pp. 443-450
Citation: Pnm. Demacker et al., Chylomicron processing in familial dysbetalipoproteinemia and familial combined hyperlipidemia studied with vitamin A and E as markers: a new physiological concept, ATHEROSCLER, 149(1), 2000, pp. 169-180
Authors:
de Bont, N
Netea, MG
Demacker, PNM
Kullberg, BJ
van der Meer, JWM
Stalenhoef, AFH
Citation: N. De Bont et al., Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae, EUR J CL IN, 30(9), 2000, pp. 818-822
Authors:
Smilde, TJ
van den Berkmortel, FW
Wollersheim, H
van Langen, H
Kastelein, JJ
Stalenhoef, AFH
Citation: Tj. Smilde et al., The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia, EUR J CL IN, 30(6), 2000, pp. 473-480
Authors:
van den Berkmortel, FWPJ
Demacker, PNM
Wollersheim, H
Thien, T
Stalenhoef, AFH
Citation: Fwpj. Van Den Berkmortel et al., Smoking or its cessation does not alter the susceptibility to in vitro LDLoxidation, EUR J CL IN, 30(11), 2000, pp. 972-979
Citation: J. De Graaf et al., Familial chylomicronemia caused by a novel type of mutation in the APOE-CI-CIV-CII gene cluster encompassing both the APOCII gene and the first APOCIV gene mutation: APOCII-CIVNijmegen, BIOC BIOP R, 273(3), 2000, pp. 1084-1087